Exact Mass: 696.3329814

Exact Mass Matches: 696.3329814

Found 111 metabolites which its exact mass value is equals to given mass value 696.3329814, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Thalicarpin

Thalicarpine

C41H48N2O8 (696.3410488000001)


C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent C1907 - Drug, Natural Product

   

Olitorin

7,11-dihydroxy-5-[(4-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-15-methyl-14-(5-oxo-2,5-dihydrofuran-3-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-2-carbaldehyde

C35H52O14 (696.3356891999999)


Isolated from Corchorus olitorius (Jews mallow). Olitorin is found in tea, herbs and spices, and green vegetables. Olitorin is found in green vegetables. Olitorin is isolated from Corchorus olitorius (Jews mallow D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   

Cenicriviroc

8-(4-(2-Butoxyethoxy)phenyl)-1,2,3,4-tetrahydro-1-(2-methylpropyl)-N-(4-((S)-((1-propyl-1H-imidazol-5-yl)methyl)sulfinyl)phenyl)-1-benzazocine-5-carboxamide

C41H52N4O4S (696.3709072)


   

Periplocin

3-[5,14-dihydroxy-3-[4-methoxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

C36H56O13 (696.3720726)


   

Periplocin

(3?,5?)-3-[(2,6-Dideoxy-4-O-?-D-glucopyranosyl-3-O-methyl-?-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-card-20(22)-enolide; Periplocin (6CI,7CI,8CI); (3?,5?)-3-[(2,6-Dideoxy-4-O-?-D-glucopyranosyl-3-O-methyl-?-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxycard-20(22)-enolide; Periplocoside; Periplogenin 3-O-[?-D-glucopyranosyl-(1?4)-?-D-cymaropyranoside]

C36H56O13 (696.3720726)


Origin: Plant; SubCategory_DNP: Triterpenoids Periplocin is a natural product found in Periploca sepium, Periploca forrestii, and other organisms with data available. Periplocin is a cardiotonic steroid isolated from root-bark Periploca sepium Bunge. Periplocin promotes tumor cell apoptosis and inhibits tumor growth. Periplocin has the potential to facilitate wound healing through the activation of Src/ERK and PI3K/Akt pathways mediated by Na/K-ATPase[1][2]. Periplocin is a cardiotonic steroid isolated from root-bark Periploca sepium Bunge. Periplocin promotes tumor cell apoptosis and inhibits tumor growth. Periplocin has the potential to facilitate wound healing through the activation of Src/ERK and PI3K/Akt pathways mediated by Na/K-ATPase[1][2].

   

PERIPLOGENIN 3-O-BETA-GLUCOPYRANOSYL-(1-4)-BETA-SARMENTOPYRANOSIDE

3-[(3S,5S,8R,9S,10R,13R,14S,17R)-5,14-dihydroxy-3-[(2R,4S,5S,6R)-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

C36H56O13 (696.3720726)


Periplogenin 3-[O-|A-glucopyranosyl-(1 inverted exclamation marku4)-|A-sarmentopyranoside] is a natural product found in Periploca sepium with data available.

   
   
   
   

Cucurbitacin G 2-O-beta-D-glucopyranoside

Cucurbitacin G 2-O-beta-D-glucopyranoside

C36H56O13 (696.3720726)


   
   
   
   

rel-(2R,3S,6R,7S,8S,9S,13R,14S,15S)-(4E,11E)-8,14,15-triacetoxy-3-(benzoyloxy)-6,9-epoxy-9-hydroxy-7-(tigloyloxy)jatropha-4,11-diene

rel-(2R,3S,6R,7S,8S,9S,13R,14S,15S)-(4E,11E)-8,14,15-triacetoxy-3-(benzoyloxy)-6,9-epoxy-9-hydroxy-7-(tigloyloxy)jatropha-4,11-diene

C38H48O12 (696.3145608)


   
   

5-Demethoxy,8-methoxy-2,2,3,3-Tetrahydro-3,3,6,7,7,8-hexamethoxy-4-(4-methoxyphenyl)-4-phenyl-5,6-bi-1H-phenalene,

5-Demethoxy,8-methoxy-2,2,3,3-Tetrahydro-3,3,6,7,7,8-hexamethoxy-4-(4-methoxyphenyl)-4-phenyl-5,6-bi-1H-phenalene,

C45H44O7 (696.3086874)


   

2alpha,3beta,6beta,19alpha,24-pentahydroxy-11-oxo-olean-12-en-28-oic acid 28-O-beta-D-glucopyranosyl ester

2alpha,3beta,6beta,19alpha,24-pentahydroxy-11-oxo-olean-12-en-28-oic acid 28-O-beta-D-glucopyranosyl ester

C36H56O13 (696.3720726)


   

4-dehydrosarmentogenin rhamnoglucoside

4-dehydrosarmentogenin rhamnoglucoside

C35H52O14 (696.3356891999999)


   

Erysimoside

Erysimoside

C35H52O14 (696.3356891999999)


A cardenolide glycoside that consists of strophanthidin having a beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl moiety attached at position 3. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   
   
   

3,5-Bis[[2,6-dihydroxy-4-methoxy-3-methyl-5-(2-methylpropanoyl)phenyl]methyl]-2-hydroxy-3,5-dimethyl-1-(2-methylpropanoyl)-1-cyclohexene-4,6-dione

3,5-Bis[[2,6-dihydroxy-4-methoxy-3-methyl-5-(2-methylpropanoyl)phenyl]methyl]-2-hydroxy-3,5-dimethyl-1-(2-methylpropanoyl)-1-cyclohexene-4,6-dione

C38H48O12 (696.3145608)


   
   
   
   

16,17-dihydroneridienone 3-O-beta-D-glucopyranosyl-(1 -> 6)-O-beta-D-galactopyranoside

16,17-dihydroneridienone 3-O-beta-D-glucopyranosyl-(1 -> 6)-O-beta-D-galactopyranoside

C35H52O14 (696.3356891999999)


   

Trachelosperoside C1

Trachelosperoside C1

C36H56O13 (696.3720726)


   
   
   

glucosyl divaricoside

glucosyl divaricoside

C36H56O13 (696.3720726)


   
   
   
   
   

19-(formyl<*>carboxy)erysimin 4-O-alpha-L-rhamnopyranoside|3-O-alpha-L-rhamnopyranosyl-(1->4)-beta-D-digitoxopyranosyl cheiranthidin|cheiranthoside X|cheiranthoside XI

19-(formyl<*>carboxy)erysimin 4-O-alpha-L-rhamnopyranoside|3-O-alpha-L-rhamnopyranosyl-(1->4)-beta-D-digitoxopyranosyl cheiranthidin|cheiranthoside X|cheiranthoside XI

C35H52O14 (696.3356891999999)


   

2alpha,3beta,19alpha,23,24-pentahydroxy-11-oxo-olean-12-en-28-oic acid 28-O-beta-D-glucopyranosyl ester

2alpha,3beta,19alpha,23,24-pentahydroxy-11-oxo-olean-12-en-28-oic acid 28-O-beta-D-glucopyranosyl ester

C36H56O13 (696.3720726)


   

2,2,3,3-Tetrahydro-3,3,6,7,7,8-hexamethoxy-4-(4-methoxyphenyl)-4-phenyl-5,6-bi[1H-phenalene]

2,2,3,3-Tetrahydro-3,3,6,7,7,8-hexamethoxy-4-(4-methoxyphenyl)-4-phenyl-5,6-bi[1H-phenalene]

C45H44O7 (696.3086874)


   

3beta-(O4(?)-beta-D-Glucopyranosyl-beta-D-glucopyranosyloxy)-14-hydroxy-14beta-carda-5,20(22)-dienolid|3beta-(O4(?)-beta-D-glucopyranosyl-beta-D-glucopyranosyloxy)-14-hydroxy-14beta-carda-5,20(22)-dienolide

3beta-(O4(?)-beta-D-Glucopyranosyl-beta-D-glucopyranosyloxy)-14-hydroxy-14beta-carda-5,20(22)-dienolid|3beta-(O4(?)-beta-D-glucopyranosyl-beta-D-glucopyranosyloxy)-14-hydroxy-14beta-carda-5,20(22)-dienolide

C35H52O14 (696.3356891999999)


   

cannogenol-beta-D-glucosyl-beta-D-cymaroside

cannogenol-beta-D-glucosyl-beta-D-cymaroside

C36H56O13 (696.3720726)


   

9-{6-[(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2,3-dimethoxyphenoxy}-1,2,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

9-{6-[(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2,3-dimethoxyphenoxy}-1,2,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

C41H48N2O8 (696.3410488000001)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.738 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.733

   

C35H52O14_Carda-5,20(22)-dienolide, 3-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-14-hydroxy-, (3beta)

NCGC00385195-01_C35H52O14_Carda-5,20(22)-dienolide, 3-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-14-hydroxy-, (3beta)-

C35H52O14 (696.3356891999999)


   

C35H52O14_Carda-5,17-dienolide, 3-[(3-O-hexopyranosylhexopyranosyl)oxy]-14-hydroxy-, (17E)

NCGC00384532-01_C35H52O14_Carda-5,17-dienolide, 3-[(3-O-hexopyranosylhexopyranosyl)oxy]-14-hydroxy-, (17E)-

C35H52O14 (696.3356891999999)


   

Thaliblastine

Thaliblastine

C41H48N2O8 (696.3410488000001)


Formula(Parent): C41H48N2O8; Origin: Plant; Bottle Name:Thalicarpine hydrochloride; PRIME Parent Name:Thalicarpine; PRIME in-house No.:V0344; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids Origin: Plant; Formula(Parent): C41H48N2O8; Bottle Name:Thalicarpine hydrochloride; PRIME Parent Name:Thalicarpine; PRIME in-house No.:V0344; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids

   

Olitoriside

Olitoriside

C35H52O14 (696.3356891999999)


Origin: Plant, Cardanolides

   
   

Olitorin

7,11-dihydroxy-5-[(4-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-15-methyl-14-(5-oxo-2,5-dihydrofuran-3-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-2-carbaldehyde

C35H52O14 (696.3356891999999)


D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   

OOV-PI

1-(9Z-octadecenoyl)-2-(5-oxo-valeroyl)-sn-glycero-3-phospho-(1-myo-inositol)

C32H57O14P (696.3485751999999)


   

Fucoxanthinol 3-sulphate

(3S,5R,6R,3S,5R,6S)-5,6-epoxy-5,3-dihydroxy-8-oxo-6,7-didehydro-5,6,5,6,7,8-hexahydro-beta,beta-caroten-3-yl sulphate

C40H56O8S (696.3695696000001)


   
   

Candesartan methyl ester N1-trityl analog

Candesartan methyl ester N1-trityl analog

C44H36N6O3 (696.2848746)


   

2-benzofuran-1,3-dione,2-hydroxyethyl prop-2-enoate,methyl 2-methylprop-2-enoate,oxiran-2-ylmethyl 7,7-dimethyloctanoate,styrene

2-benzofuran-1,3-dione,2-hydroxyethyl prop-2-enoate,methyl 2-methylprop-2-enoate,oxiran-2-ylmethyl 7,7-dimethyloctanoate,styrene

C39H52O11 (696.3509442000001)


   

N,N-Bis(11-hydroxyundecanyl)bipyridinium diperchlorate (Viologen)

N,N-Bis(11-hydroxyundecanyl)bipyridinium diperchlorate (Viologen)

C32H54Cl2N2O10 (696.3155324)


   
   

Cenicriviroc

(5E)-8-[4-(2-butoxyethoxy)phenyl]-1-(2-methylpropyl)-N-[4-[(3-propylimidazol-4-yl)methylsulfinyl]phenyl]-3,4-dihydro-2H-1-benzazocine-5-carboxamide

C41H52N4O4S (696.3709072)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist D065100 - CCR5 Receptor Antagonists Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

NY IV34 1

4H-Dibenzo(de,g)quinoline, 9-(4,5-dimethoxy-2-((1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl)methyl)phenoxy)-5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S-(R*,R*))- (9CI)

C41H48N2O8 (696.3410488000001)


C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent C1907 - Drug, Natural Product

   

rifamycin SV(1-)

rifamycin SV(1-)

C37H46NO12- (696.3019856000001)


A phenolate anion obtained by deprotonation of the 5-hydroxy group of rifamycin SV. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

digitoxigenin 3-O-[beta-D-glucosyl-(1->4)-alpha-L-acofrioside]

digitoxigenin 3-O-[beta-D-glucosyl-(1->4)-alpha-L-acofrioside]

C36H56O13 (696.3720726)


   

(8xi,9xi,14xi,17xi)-3-{[(4xi)-2,6-dideoxy-4-O-(D-glucopyranosyl)-beta-D-erythro-hexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide

(8xi,9xi,14xi,17xi)-3-{[(4xi)-2,6-dideoxy-4-O-(D-glucopyranosyl)-beta-D-erythro-hexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide

C35H52O14 (696.3356891999999)


   

(8xi,9xi,14xi,17xi)-3-{[(4xi)-2,6-dideoxy-4-O-(D-glucopyranosyl)-3-O-methyl-beta-D-erythro-hexopyranosyl]oxy}-5,14-dihydroxycard-20(22)-enolide

(8xi,9xi,14xi,17xi)-3-{[(4xi)-2,6-dideoxy-4-O-(D-glucopyranosyl)-3-O-methyl-beta-D-erythro-hexopyranosyl]oxy}-5,14-dihydroxycard-20(22)-enolide

C36H56O13 (696.3720726)


   

[(2S,3S,6S)-6-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,6S)-6-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C35H52O12S (696.3179312)


   

Thalicarpine

Thalicarpine

C41H48N2O8 (696.3410488000001)


C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent C1907 - Drug, Natural Product

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(1r,2e,4r,5s,7s,8r,9s,10e,13s,14r,15s)-7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

(1r,2e,4r,5s,7s,8r,9s,10e,13s,14r,15s)-7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

C38H48O12 (696.3145608)


   

7-[(6-{[(4,6-dihydroxy-2-methyloxan-3-yl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl)oxy]-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

7-[(6-{[(4,6-dihydroxy-2-methyloxan-3-yl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl)oxy]-3a,5a-dihydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde

C35H52O14 (696.3356891999999)


   

4-{3-[(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]butyl}-3,5,5-trimethylcyclohex-2-en-1-one

4-{3-[(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]butyl}-3,5,5-trimethylcyclohex-2-en-1-one

C31H52O17 (696.3204342)


   

7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-[(2-methylbut-2-enoyl)oxy]-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-[(2-methylbut-2-enoyl)oxy]-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

C38H48O12 (696.3145608)


   

{4,8,9-trihydroxy-6,16,18-trimethoxy-11-propyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-(3-ethyl-2,5-dioxopyrrolidin-1-yl)benzoate

{4,8,9-trihydroxy-6,16,18-trimethoxy-11-propyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-(3-ethyl-2,5-dioxopyrrolidin-1-yl)benzoate

C38H52N2O10 (696.3621772)


   

(1r,2r,3as,3bs,8s,9ar,9br,11ar)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[(2r,5r)-2,5,6-trihydroxy-6-methyl-3-oxoheptan-2-yl]-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

(1r,2r,3as,3bs,8s,9ar,9br,11ar)-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-[(2r,5r)-2,5,6-trihydroxy-6-methyl-3-oxoheptan-2-yl]-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H56O13 (696.3720726)


   

(1r,3as,3br,5as,7s,9ar,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5r,6r)-4-hydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

(1r,3as,3br,5as,7s,9ar,9bs,11ar)-3a-hydroxy-7-{[(2r,4s,5r,6r)-4-hydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

C35H52O14 (696.3356891999999)


   

(4r)-4-[(3s)-3-{[(2r,3r,4r,5s,6r)-5-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-3,5,5-trimethylcyclohex-2-en-1-one

(4r)-4-[(3s)-3-{[(2r,3r,4r,5s,6r)-5-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl]-3,5,5-trimethylcyclohex-2-en-1-one

C31H52O17 (696.3204342)


   

4-[(1r,3as,3br,7s,9ar,9bs,11ar)-7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

4-[(1r,3as,3br,7s,9ar,9bs,11ar)-7-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a-hydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5h-furan-2-one

C35H52O14 (696.3356891999999)


   

3a-hydroxy-7-[(4-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

3a-hydroxy-7-[(4-hydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carboxylic acid

C35H52O14 (696.3356891999999)


   

4,7-dihydroxy-1-(5-methyl-6-phenylhexyl)-6-[(6-methyl-9-phenylnon-4-enoyl)oxy]-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

4,7-dihydroxy-1-(5-methyl-6-phenylhexyl)-6-[(6-methyl-9-phenylnon-4-enoyl)oxy]-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

C38H48O12 (696.3145608)


   

(2r,3r,4r,4ar,6ar,6bs,8as,11s,12s,12as,14ar,14br)-2,3,12-trihydroxy-11-(hydroxymethyl)-4,6a,6b,12,14b-pentamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid

(2r,3r,4r,4ar,6ar,6bs,8as,11s,12s,12as,14ar,14br)-2,3,12-trihydroxy-11-(hydroxymethyl)-4,6a,6b,12,14b-pentamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid

C36H56O13 (696.3720726)


   

(2s,5s,8s,14s,17s,20s)-14-benzyl-4,7,16,19-tetrahydroxy-2,5-diisopropyl-17-[(1r)-1-[(2-methylbut-3-en-2-yl)oxy]ethyl]-22-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁸,¹²]tricosa-1(23),3,6,15,18-pentaen-13-one

(2s,5s,8s,14s,17s,20s)-14-benzyl-4,7,16,19-tetrahydroxy-2,5-diisopropyl-17-[(1r)-1-[(2-methylbut-3-en-2-yl)oxy]ethyl]-22-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁸,¹²]tricosa-1(23),3,6,15,18-pentaen-13-one

C36H52N6O6S (696.3668852000001)


   

(1r,2e,4s,5s,7r,8s,9r,10e,13s,14s,15r)-7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

(1r,2e,4s,5s,7r,8s,9r,10e,13s,14s,15r)-7,8,14-tris(acetyloxy)-13-hydroxy-1,5,9,12,12-pentamethyl-15-{[(2e)-2-methylbut-2-enoyl]oxy}-16-oxatricyclo[11.2.1.0³,⁷]hexadeca-2,10-dien-4-yl benzoate

C38H48O12 (696.3145608)


   

4-{7-[(6-{[(4,6-dihydroxy-2-methyloxan-3-yl)oxy]methyl}-3,5-dihydroxy-4-methoxyoxan-2-yl)oxy]-3a,5a-dihydroxy-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-5h-furan-2-one

4-{7-[(6-{[(4,6-dihydroxy-2-methyloxan-3-yl)oxy]methyl}-3,5-dihydroxy-4-methoxyoxan-2-yl)oxy]-3a,5a-dihydroxy-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-5h-furan-2-one

C36H56O13 (696.3720726)